Amylin antagonist peptides and uses therefor

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Insulin; related peptides

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530324, A61K 3822, C07K 14575

Patent

active

055809537

ABSTRACT:
Compounds which inhibit amylin activity are provided. These compounds may be used in the treatment of conditions where it is of benefit to reduce amylin activity, including the treatment of Type 2 diabetes mellitus, impaired glucose tolerance, obesity and insulin resistance.

REFERENCES:
patent: 3941763 (1976-03-01), Sarantakis
patent: 5124314 (1992-06-01), Cooper
patent: 5175146 (1992-12-01), Basava
patent: 5264372 (1993-11-01), Beaumont et al.
patent: 5266561 (1991-11-01), Cooper et al.
Breimer et al. Biochem. J., 255, 377-390, 1988.
Lehninger, A., Principles of Biochemistry, pp. 100-103.
Leighton, B., et al., Nature, vol. 335, No. 6191, pp. 632-635 (13 Oct. 1988).
Cooper, G. J. S., et al. Proc. Natl. Acad. Sci USA, vol. 85, pp. 7763-7766 (Oct. 1988).
Roberts, A. N., et al., Proc. Natl. Acad. Sci USA, vol. 86, pp. 9662-9666 (Dec. 1989).
Munson, P. J., et al., Analytical Biochemistry, 107, pp. 220-239 (1980).
Cooper, G. J. S., et al., Biochimica et Biophysica Acta., 1014, pp. 247-258 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amylin antagonist peptides and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amylin antagonist peptides and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amylin antagonist peptides and uses therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-786417

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.